Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent.

Abstract

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an autosomal recessive disease occurring during childhood. The gene responsible for disease development is a ubiquitously expressed protein, IGHMBP2. Mutations in IGHMBP2 result in the loss of α-motor neurons leading to muscle atrophy in the distal limbs accompanied by respiratory complications. Although genetically and clinically distinct, proximal SMA is also caused by the loss of a ubiquitously expressed gene (SMN). Significant preclinical success has been achieved in proximal SMA using viral-based gene replacement strategies. We leveraged the technologies employed in SMA to demonstrate gene replacement efficacy in an SMARD1 animal model. Intracerebroventricular (ICV) injection of single-stranded AAV9 expressing the full-length cDNA of IGHMBP2 in a low dose led to a significant level of rescue in treated SMARD1 animals. Consistent with drastically increased survival, weight gain, and strength, the rescued animals demonstrated a significant improvement in muscle, NMJ, motor neurons, and axonal pathology. In addition, increased levels of IGHMBP2 in lumbar motor neurons verified the efficacy of the virus to transduce the target tissues. Our results indicate that AAV9-based gene replacement is a viable strategy for SMARD1, although dosing effects and potential negative impacts of high dose and ICV injection should be thoroughly investigated.

• Authors: Monir Shababi, Zhihua Feng, Eric Villalon, Christine M Sibigtroth, Erkan Y Osman, Madeline R Miller, Patricka A Williams-Simon, Abby Lombardi, Thalia H Sass, Arleigh K Atkinson, Michael L Garcia, Chien-Ping Ko, Christian L Lorson
• Journal: Molecular therapy : the journal of the American Society of Gene Therapy (Mol Ther) Vol. 24 Issue 5 Pg. 855-66 (05 2016) ISSN: 1525-0024 [Electronic] United States
• PMID: 26860981 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• DNA-Binding Proteins
• IGHMBP2 protein, human
• Transcription Factors

Topics

• Animals
• Body Weight
• DNA-Binding Proteins (genetics)
• Dependovirus (genetics)
• Disease Models, Animal
• Dose-Response Relationship, Drug
• Female
• Genetic Therapy
• Genetic Vectors (administration & dosage)
• Humans
• Male
• Mice
• Muscular Atrophy, Spinal (genetics, therapy)
• Mutation
• Respiratory Distress Syndrome, Newborn (genetics, therapy)
• Survival Analysis
• Transcription Factors (genetics)